Trials / Conditions / Peripheral T-cell Lymphoma NOS
Peripheral T-cell Lymphoma NOS
4 registered clinical trials studyying Peripheral T-cell Lymphoma NOS.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Interleukin-15 (IL-5) in Combination With Avelumab (Bavencio) in Relapsed/Refractory Mature T-cell Malignancie NCT03905135 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms NCT03493451 | BeiGene | Phase 2 |
| Unknown | CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma NCT02742727 | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | Phase 1 / Phase 2 |
| Unknown | CHOP vs GEM-P in 1st Line Treatment of T-cell Lymphoma, Multicentre Phase II Study NCT01719835 | Royal Marsden NHS Foundation Trust | Phase 2 |